738 A phase 1/2 study investigating the safety and efficacy of autologous TAC T cells in subjects with unresectable, locally advanced or metastatic claudin 18.2+ solid tumors
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1797628960523157504 |
|---|---|
| author | Daniel J Olson Ecaterina Dumbrava Benjamin Schlechter Maria Apostolopoulou Kara Moss Deyaa Adib Sam Saibil Martin Gutierez Syma Iqbal Davendra Sohal |
| author_facet | Daniel J Olson Ecaterina Dumbrava Benjamin Schlechter Maria Apostolopoulou Kara Moss Deyaa Adib Sam Saibil Martin Gutierez Syma Iqbal Davendra Sohal |
| author_sort | Daniel J Olson |
| collection | DOAJ |
| first_indexed | 2024-03-11T10:47:40Z |
| format | Article |
| id | doaj.art-05a7d050fb7d400abbb74c73c3adc8a9 |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-03-11T10:47:40Z |
| publishDate | 2023-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-05a7d050fb7d400abbb74c73c3adc8a92023-11-13T22:15:07ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.0738738 A phase 1/2 study investigating the safety and efficacy of autologous TAC T cells in subjects with unresectable, locally advanced or metastatic claudin 18.2+ solid tumorsDaniel J Olson0Ecaterina Dumbrava1Benjamin Schlechter2Maria Apostolopoulou3Kara Moss4Deyaa Adib5Sam Saibil6Martin Gutierez7Syma Iqbal8Davendra Sohal91University of Chicago, Chicago, IL, USA2The University of Texas MD Anderson Cancer Center, Houston, TX, USA9Dana-Farber Cancer Institute, Boston, MA, USA7Triumvira Immunologics Inc., Falmouth, MA, USA8Triumvira Immunologics, Austin, TX, USA8Triumvira Immunologics, Austin, TX, USA3University Health Network Princess Margaret, Toronto, ON, Canada4Hackensack University Medical Center, Hackensack, NJ, USA5Usc Norris Comprehensive Cancer Ctr Div Onc, Los Angeles, CA, USA6University of Cincinnati Cancer Center, Cincinnati, OH, USA |
| spellingShingle | Daniel J Olson Ecaterina Dumbrava Benjamin Schlechter Maria Apostolopoulou Kara Moss Deyaa Adib Sam Saibil Martin Gutierez Syma Iqbal Davendra Sohal 738 A phase 1/2 study investigating the safety and efficacy of autologous TAC T cells in subjects with unresectable, locally advanced or metastatic claudin 18.2+ solid tumors Journal for ImmunoTherapy of Cancer |
| title | 738 A phase 1/2 study investigating the safety and efficacy of autologous TAC T cells in subjects with unresectable, locally advanced or metastatic claudin 18.2+ solid tumors |
| title_full | 738 A phase 1/2 study investigating the safety and efficacy of autologous TAC T cells in subjects with unresectable, locally advanced or metastatic claudin 18.2+ solid tumors |
| title_fullStr | 738 A phase 1/2 study investigating the safety and efficacy of autologous TAC T cells in subjects with unresectable, locally advanced or metastatic claudin 18.2+ solid tumors |
| title_full_unstemmed | 738 A phase 1/2 study investigating the safety and efficacy of autologous TAC T cells in subjects with unresectable, locally advanced or metastatic claudin 18.2+ solid tumors |
| title_short | 738 A phase 1/2 study investigating the safety and efficacy of autologous TAC T cells in subjects with unresectable, locally advanced or metastatic claudin 18.2+ solid tumors |
| title_sort | 738 a phase 1 2 study investigating the safety and efficacy of autologous tac t cells in subjects with unresectable locally advanced or metastatic claudin 18 2 solid tumors |
| work_keys_str_mv | AT danieljolson 738aphase12studyinvestigatingthesafetyandefficacyofautologoustactcellsinsubjectswithunresectablelocallyadvancedormetastaticclaudin182solidtumors AT ecaterinadumbrava 738aphase12studyinvestigatingthesafetyandefficacyofautologoustactcellsinsubjectswithunresectablelocallyadvancedormetastaticclaudin182solidtumors AT benjaminschlechter 738aphase12studyinvestigatingthesafetyandefficacyofautologoustactcellsinsubjectswithunresectablelocallyadvancedormetastaticclaudin182solidtumors AT mariaapostolopoulou 738aphase12studyinvestigatingthesafetyandefficacyofautologoustactcellsinsubjectswithunresectablelocallyadvancedormetastaticclaudin182solidtumors AT karamoss 738aphase12studyinvestigatingthesafetyandefficacyofautologoustactcellsinsubjectswithunresectablelocallyadvancedormetastaticclaudin182solidtumors AT deyaaadib 738aphase12studyinvestigatingthesafetyandefficacyofautologoustactcellsinsubjectswithunresectablelocallyadvancedormetastaticclaudin182solidtumors AT samsaibil 738aphase12studyinvestigatingthesafetyandefficacyofautologoustactcellsinsubjectswithunresectablelocallyadvancedormetastaticclaudin182solidtumors AT martingutierez 738aphase12studyinvestigatingthesafetyandefficacyofautologoustactcellsinsubjectswithunresectablelocallyadvancedormetastaticclaudin182solidtumors AT symaiqbal 738aphase12studyinvestigatingthesafetyandefficacyofautologoustactcellsinsubjectswithunresectablelocallyadvancedormetastaticclaudin182solidtumors AT davendrasohal 738aphase12studyinvestigatingthesafetyandefficacyofautologoustactcellsinsubjectswithunresectablelocallyadvancedormetastaticclaudin182solidtumors |